.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Deloitte
Mallinckrodt
Daiichi Sankyo
Cantor Fitzgerald
QuintilesIMS
Novartis
Chubb
Chinese Patent Office
McKinsey

Generated: July 23, 2017

DrugPatentWatch Database Preview

Atropine sulfate; difenoxin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for atropine sulfate; difenoxin hydrochloride and what is the scope of atropine sulfate; difenoxin hydrochloride freedom to operate?

Atropine sulfate; difenoxin hydrochloride
is the generic ingredient in two branded drugs marketed by Sebela Ireland Ltd and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for atropine sulfate; difenoxin hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: atropine sulfate; difenoxin hydrochloride

Tradenames:2
Patents:1
Applicants:1
NDAs:1
Drug Master File Entries: see list22
Suppliers / Packagers: see list1
Clinical Trials: see list2,939
Therapeutic Class:Gastrointestinal Agents
Drug Prices:see low prices
DailyMed Link:atropine sulfate; difenoxin hydrochloride at DailyMed

Pharmacology for Ingredient: atropine sulfate; difenoxin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd
MOTOFEN HALF-STRENGTH
atropine sulfate; difenoxin hydrochloride
TABLET;ORAL017744-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Sebela Ireland Ltd
MOTOFEN
atropine sulfate; difenoxin hydrochloride
TABLET;ORAL017744-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: atropine sulfate; difenoxin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd
MOTOFEN
atropine sulfate; difenoxin hydrochloride
TABLET;ORAL017744-002Approved Prior to Jan 1, 19823,646,207► Subscribe
Sebela Ireland Ltd
MOTOFEN HALF-STRENGTH
atropine sulfate; difenoxin hydrochloride
TABLET;ORAL017744-001Approved Prior to Jan 1, 19823,646,207► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
US Department of Justice
Chinese Patent Office
Accenture
Covington
Queensland Health
Boehringer Ingelheim
Novartis
Farmers Insurance
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot